Navigation Links
Patent Attorney John Rizvi Speaks at FIME International Medical Expo
Date:8/5/2009

The FIME 2009 International Medical Expo is the largest and most comprehensive medical exposition of its kind. John Rizvi will deliver a presentation titled, "Preservation of Legal Rights in Medical Innovations" at the FIME 2009 International Medical Expo in Miami Beach.

Miami, FL (PRWEB) August 5, 2009 -- On August 13, 2009 at 1:00 PM, attorney John Rizvi will deliver a presentation titled, "Preservation of Legal Rights in Medical Innovations" at the FIME 2009 International Medical Expo in Miami Beach.

Florida has one of the country's largest medical device sectors. Florida ranks second in the U.S. for number of FDA-registered medical device establishments, according to the FDA (2007). Over 20,000 Floridians work in this sector.

The FIME 2009 International Medical Expo is the largest and most comprehensive medical exposition of its kind. The exposition will feature medical manufacturers from around the world. It is held at the Miami Beach Convention Center, with over 500,000 square feet of exhibitor space. The four types of featured attendees are medical equipment, medical products, medical services and medical technology companies.

South Florida has seen steady growth in the medical device industry over the past ten years and John Rizvi, a patent attorney who specializes in patenting medical devices, is giving a presentation to educate medical technology companies on the importance of patenting new inventions.

"Patents help eliminate competition by giving patent holders the right to prevent anyone else from making, using, selling, or importing competing products in their market. This allows a patent holder to maintain monopoly pricing and avoids the product becoming a commodity," said Rizvi.

Patents for medical device companies have become increasingly important as more competitors from overseas and nationally are laun
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Page: 1 2

Related biology technology :

1. Dynavax Issued Landmark Patent Covering Second-Generation TLR9 Agonists
2. VisEn Medical Files Action to Invalidate New Caliper Life Sciences Patent
3. Pressure BioSciences, Inc. Issued First Patent in Canada
4. Oncolytics Biotech Inc. Announces Issuance of 23rd U.S. Patent
5. CODA Genomics Announces Issuance of Optimized Synthetic Gene Production Patent
6. Forest Laboratories Announces Federal Appeals Court Upholds Lexapro(R) Patent Decision
7. Weil Gotshal Wins Major Victory for Applera; Secures Summary Judgment Invalidating Three Patents
8. Angiotech receives favourable patent decision from New Zealands Intellectual Property Office
9. Angiotech reaches agreement with Johnson & Johnson to settle outstanding patent litigation
10. Warner Chilcott Announces New Information in USPTO Reexamination of Taclonex Patent
11. Intellect Neurosciences, Inc. Obtains Validation of European Patent for Alzheimers Vaccine in 19 Countries
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... 2015 Research ... the addition of Jain PharmaBiotech,s new report ... to their offering. The ... fluorescence in situ hybridization (FISH), comparative genomic ... includes application of nanobiotechnology, microarrays, real-time polymerase ...
(Date:9/2/2015)... , Sept. 2, 2015 Australian prostate cancer ... prestigious Australian science prize recognising ,outstanding, science that uses ... to globally launch a novel prostate cancer diagnostic test ... high level consortium taking out the peer-reviewed Australian Museum ... Research. This prize is awarded for ...
(Date:9/2/2015)... , September 2, 2015 BiondVax ... of the National Institute of Allergy and Infectious Diseases (NIAID), ... the Department of Health and Human Services (HHS), to launch ... the United States in the 2015-16 timeframe. ... vaccine candidate, Multimeric-001 (M-001), as a primer vaccine, which would ...
(Date:9/2/2015)... ... September 02, 2015 , ... Temarry Recycling's new $100,000 ... to energy process and continue to contribute to the sustainability of our natural ... to Energy process has been operating at their Mexico facility, Recicladora Temarry, for ...
Breaking Biology Technology:Global Cytogenetics Technologies Study 2015-2025 - Latest Markets and Companies Analysis 2Global Cytogenetics Technologies Study 2015-2025 - Latest Markets and Companies Analysis 3Prostate Cancer Company Minomic Wins Prestigious Eureka Science Prize 2Prostate Cancer Company Minomic Wins Prestigious Eureka Science Prize 3BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health 2BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health 3Temarry Recycling’s New $100,000 Waste to Energy Renovation 2
... EVRY, France, May 5 Novagali Pharma, ... the Company,s,Investigational New Drug Application (IND) to ... (Nova21027), for the treatment of glaucoma has ... Administration (FDA). Catioprost(R) is a,topical ocular proprietary ...
... Insmed Inc. (Nasdaq: INSM ), a ... from The NASDAQ Stock Market that it has regained ... requirement, and further, that it currently complies with all ... with the bid price rule, the Company was required ...
... lamps have been used to control outbreaks of measles, ... and hospitals since the 1930,s. UVGI (Ultraviolet Germicidal Irradiation) ... 1955 Mumps epidemic and helped eliminate a Varicella (Chicken ... recently, UVGI units were installed into Hong Kong hospitals ...
Cached Biology Technology:Novagali Pharma Announces FDA Clearance of IND for Phase III of Catioprost(R), its Cationic Emulsion of Latanoprost in Patients With Glaucoma 2Insmed Regains NASDAQ Compliance 2Swine Flu Fears Generate Interest in UV Disinfection Technologies...Again 2
(Date:8/10/2015)... and TELTOW, Germany , August ... (SMI), a world leader in Eye Tracking Technology ... of its OEM Eye Tracking Platform for integration into ... Platform contains reference designs for seamless integration of eye ... virtual reality HMDs and augmented reality smart glasses. Omnivision,s ...
(Date:8/6/2015)... Calif. , Aug. 6, 2015  Today, ... will visit Crossmatch ™ to learn firsthand ... and protect data. Crossmatch is a world leader ... technologies and expertise are helping federal agencies and ... and security.   "The vast majority ...
(Date:8/6/2015)... Aug. 6, 2015 Synaptics Inc. (NASDAQ: ... interface solutions, today announced collaboration with Microsoft on ... 10. Microsoft leveraged Synaptics, deep expertise in human ... Through stringent testing, Synaptics, advanced ... with Microsoft,s Precision TouchPad (PTP) specification empowering OEMs ...
Breaking Biology News(10 mins):SMI Completes OEM Eye Tracking Platform to Cover All Consumer Displays 2SMI Completes OEM Eye Tracking Platform to Cover All Consumer Displays 3Rep. Honda to Visit Crossmatch in Redwood City 2Synaptics Chosen for Human Interface Co-Development on Windows 10 2
... and instead reduce fossil-fuel use for the sake of the ... the University of Washington and one from the University of ... issue of the journal Nature (Jan. 26) that ... the environment as a reason to curb the use of ...
... MIT researchers have discovered that certain photosynthetic ocean ... viruses are really con artists carrying genetic material taken ... host into using its own machinery to activate the ... relationship. The con occurs when a grifter ...
... officers can now register online to the 2012 General ... brings together over 10,000 scientists from all over the ... and space sciences. EGU,s General Assembly is an ... recent developments in topics as diverse as shale gas ...
Cached Biology News:Commentary in Nature: Can economy bear what oil prices have in store? 2Commentary in Nature: Can economy bear what oil prices have in store? 3Viruses con bacteria into working for them 2Viruses con bacteria into working for them 3European Geosciences Union General Assembly, April 22-27, 2012, Vienna, Austria 2
... The Genome Sequencer 20 System revolutionizes DNA ... parallel fashion. The Genome Sequencer 20 ... Reagents and consumables for library construction, ... mapping and de novo assembly ...
Compound(s) tested through a broad panel of 38 ligand binding and enzyme assays targeting the Central Nervous System. Used to determine selectivity and potential CV/Renal liabilities of compounds....
... Normal Human Serum-Single Donor • Human ... who are found to be negative by ... (s) (HIV-1Ag), Antibodies to Human Immunodeficiency Virus ... Nonreactive for Hepatitis B Surface Antigen (HbsAg) ...
Compound(s) screened through any number of client selected assays. Client also selects number of concentrations and replicates....
Biology Products: